Effects and persistence of denosumab in postmenopausal women with osteoporosis.
Phase of Trial: Phase IV
Latest Information Update: 12 Oct 2015
At a glance
- Drugs Denosumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 26 Dec 2014 New trial record
- 01 Apr 2012 Recruitment completed, according to interim results presented at 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.